Article Type
Changed
Tue, 02/12/2019 - 15:21
Display Headline
Cancer genetics for the clinician: Recommendations on screening for BRCA1 and BRCA2 mutations
Article PDF
Author and Disclosure Information

Brian A. Clark, PhD, MD
Director of Medical Genetics, Taussig Cancer Center, Cleveland Clinic

Address: Brian A. Clark, PhD, MD, Taussig Cancer Center, T10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; clarkb@cc.ccf.org

Issue
Cleveland Clinic Journal of Medicine - 67(6)
Publications
Topics
Page Number
408-412, 414
Sections
Author and Disclosure Information

Brian A. Clark, PhD, MD
Director of Medical Genetics, Taussig Cancer Center, Cleveland Clinic

Address: Brian A. Clark, PhD, MD, Taussig Cancer Center, T10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; clarkb@cc.ccf.org

Author and Disclosure Information

Brian A. Clark, PhD, MD
Director of Medical Genetics, Taussig Cancer Center, Cleveland Clinic

Address: Brian A. Clark, PhD, MD, Taussig Cancer Center, T10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; clarkb@cc.ccf.org

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 67(6)
Issue
Cleveland Clinic Journal of Medicine - 67(6)
Page Number
408-412, 414
Page Number
408-412, 414
Publications
Publications
Topics
Article Type
Display Headline
Cancer genetics for the clinician: Recommendations on screening for BRCA1 and BRCA2 mutations
Display Headline
Cancer genetics for the clinician: Recommendations on screening for BRCA1 and BRCA2 mutations
Sections
Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media